Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of CD19 CAR-T Cells Therapy for Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma in Children/Young Adults

NCT05333302 is registered in ClinicalTrials.gov with Belarusian Research Center for Pediatric Oncology, Hematology and Immunology as lead sponsor.

NCT NCT05333302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05333302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of CD19 CAR-T Cells Therapy for Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma in Children/Young Adults
Lead sponsor
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Phase
Phase 1
Overall status
Recruiting
Start date
October 26, 2020
Completion date
June 30, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukemia, lymphoblastic b-cell lymphoma